<SEC-DOCUMENT>0001564590-21-001028-index.html : 20210113
<SEC-HEADER>0001564590-21-001028.hdr.sgml : 20210113
<ACCEPTANCE-DATETIME>20210112181130
ACCESSION NUMBER:		0001564590-21-001028
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210112
ITEM INFORMATION:		Regulation FD Disclosure
FILED AS OF DATE:		20210113
DATE AS OF CHANGE:		20210112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beam Therapeutics Inc.
		CENTRAL INDEX KEY:			0001745999
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39208
		FILM NUMBER:		21524456

	BUSINESS ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-327-8775

	MAIL ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>beam-8k_20210112.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: beam-8k_20210112.htm

</DOCUMENT>
</SEC-DOCUMENT>